Copyright: André Schweigler
Prof. Dr. med. Hortense Slevogt, senior physician at the Clinical Department of Pneumology and Infectious Diseases at the MHH and research group leader at the Helmholtz Center for Infection Research (HZI), has been appointed to the Commission on Antiinfectives, Resistance, and Therapy (ART) of the Robert Koch Institute (RKI). The ART Commission is an independent expert panel at the RKI that develops recommendations on the rational use of anti-infective agents based on current scientific evidence.